Ovarian germ cell tumour and bleomycin-induced lung injury
Open Access
- 3 July 2018
- journal article
- case report
- Published by Taylor & Francis in Southern African Journal of Gynaecological Oncology
- Vol. 10 (2) , 30-33
Abstract
Bleomycin, an antibiotic agent with antitumour activity, is an important drug in the management of many oncological malignancies such as lymphoma and germ cell tumours. These tumours are potentially curable and mostly affect young people. The potential side effects and long-term toxicities should be considered. The major limitation of bleomycin therapy is pulmonary toxicity and may be life threatening in about 10% of cases. This article reports a case of an ovarian mixed germ cell tumour, which presented with bleomycin-associated pulmonary toxicity.Keywords
This publication has 10 references indexed in Scilit:
- Pulmonary Function in Patients With Germ Cell Cancer Treated With Bleomycin, Etoposide, and CisplatinJournal of Clinical Oncology, 2016
- Germ cell tumors: Treatment consensus across all age groups through MaGIC [MalignantGerm CellInternationalCollaborative]Cancer, 2015
- Malignant Ovarian Germ Cell Tumors: Identification of Novel Prognostic Markers and Long-Term Outcome After Multimodality TreatmentJournal of Clinical Oncology, 2006
- Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumoursAnnals of Oncology, 2003
- Bleomycin-Induced PneumonitisChest, 2001
- Germ cell tumors of the ovary: Is there a role for aggressive cytoreductive surgery for nondysgerminomatous tumors?International Journal of Gynecological Cancer, 2001
- Pneumomediastinum complicating bleomycin related lung damage.British Journal of Radiology, 1998
- Reversal of bleomycin lung toxicity with corticosteroids.Thorax, 1994
- Severe bleomycin lung toxicity: reversal with high dose corticosteroids.Thorax, 1993
- The role of chest computed tomography in the diagnosis of drug-related reactionsJournal of Thoracic Imaging, 1991